Previous close | 21.00 |
Open | 22.00 |
Bid | 21.55 |
Ask | 21.95 |
Strike | 65.00 |
Expiry date | 2025-06-20 |
Day's range | 22.00 - 22.00 |
Contract range | N/A |
Volume | |
Open interest | 530 |
Gilead Sciences (GILD) reachead $85.21 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.
FOSTER CITY, Calif., October 07, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) providing an overview of the efficacy and safety of twice-yearly lenacapavir, the company’s injectable HIV-1 capsid inhibitor, for the investigational use of HIV prevention among a broad and geographically diverse range of cisgender men and gender-diverse people.
When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore...